Low Use of Oral Anticoagulant Prescribing for Secondary Stroke Prevention: Results From the Ontario Stroke Registry

Med Care. 2016 Oct;54(10):907-12. doi: 10.1097/MLR.0000000000000589.

Abstract

Background: Oral anticoagulation reduces the risk of stroke in atrial fibrillation but is often underused.

Objectives: To identify factors associated with oral anticoagulant prescribing and adherence after stroke or transient ischemic attack (TIA).

Research design: Retrospective cohort study using linked Ontario Stroke Registry and prescription claims data.

Subjects: Consecutive patients with atrial fibrillation and ischemic stroke/TIA admitted to 11 stroke centers in Ontario, Canada between 2003 and 2011.

Measures: We used modified Poisson regression models to determine predictors of anticoagulant prescribing and multiple logistic regression to determine predictors of 1-year adherence.

Results: Of the 5781 patients in the study cohort, 4235 (73%) were prescribed oral anticoagulants at discharge. Older patients were less likely to receive anticoagulation [adjusted relative risk (aRR) for each additional year=0.997; 95% confidence interval (CI), 0.995-0.998], as were those with TIA compared with ischemic stroke (aRR=0.904; 95% CI, 0.865-0.945), prior gastrointestinal bleed (aRR=0.778; 95% CI, 0.693-0.873), dementia (aRR=0.912; 95% CI, 0.856-0.973), and those from a long-term care facility (aRR=0.810; 95% CI, 0.737-0.891). After limiting the sample to those without obvious contraindications to anticoagulation, age, dementia, and long-term care residence continued to be associated with lower prescription of oral anticoagulants. One-year adherence to therapy was similar across most patient groups.

Conclusions: Age, dementia, and long-term care residence are predictors of lower oral anticoagulant use for secondary stroke prevention and represent key target areas for quality improvement initiatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Dementia / complications
  • Female
  • Humans
  • Logistic Models
  • Male
  • Medication Adherence / statistics & numerical data
  • Nursing Homes / statistics & numerical data
  • Ontario / epidemiology
  • Poisson Distribution
  • Practice Patterns, Physicians' / statistics & numerical data
  • Registries
  • Retrospective Studies
  • Stroke / complications
  • Stroke / prevention & control*

Substances

  • Anticoagulants